These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 10618073)

  • 1. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.
    Piret J; Lamontagne J; Bestman-Smith J; Roy S; Gourde P; Désormeaux A; Omar RF; Juhász J; Bergeron MG
    J Clin Microbiol; 2000 Jan; 38(1):110-9. PubMed ID: 10618073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine.
    Piret J; Roy S; Gagnon M; Landry S; Désormeaux A; Omar RF; Bergeron MG
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2933-42. PubMed ID: 12183250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment.
    Bestman-Smith J; Piret J; Désormeaux A; Tremblay MJ; Omar RF; Bergeron MG
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2229-37. PubMed ID: 11451679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium lauryl sulfate, a microbicide effective against enveloped and nonenveloped viruses.
    Piret J; Désormeaux A; Bergeron MG
    Curr Drug Targets; 2002 Feb; 3(1):17-30. PubMed ID: 11899262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases.
    Roy S; Gourde P; Piret J; Désormeaux A; Lamontagne J; Haineault C; Omar RF; Bergeron MG
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1671-81. PubMed ID: 11353610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.
    Piret J; Désormeaux A; Cormier H; Lamontagne J; Gourde P; Juhász J; Bergeron MG
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2263-70. PubMed ID: 10952566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of docusate as protective agent from herpes simplex viruses.
    Gong Y; Wen A; Cheung D; Wong M; Sacks SL
    Antiviral Res; 2001 Oct; 52(1):25-32. PubMed ID: 11530185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity.
    Neyts J; De Clercq E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):8-12. PubMed ID: 7648289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice.
    Donalisio M; Quaranta P; Chiuppesi F; Pistello M; Cagno V; Cavalli R; Volante M; Bugatti A; Rusnati M; Ranucci E; Ferruti P; Lembo D
    Biomaterials; 2016 Apr; 85():40-53. PubMed ID: 26854390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.
    Tintori C; Iovenitti G; Ceresola ER; Ferrarese R; Zamperini C; Brai A; Poli G; Dreassi E; Cagno V; Lembo D; Canducci F; Botta M
    PLoS One; 2018; 13(6):e0198478. PubMed ID: 29870553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses.
    Fujiwara M; Ashida N; Okamoto M; Mizuta T; Ide T; Hanasaki Y; Katsuura K; Sawada H; Shigeta S; Konno K; Yokota T; Baba M
    Antiviral Res; 1998 May; 38(2):141-9. PubMed ID: 9707376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran sulfate can act as an artificial receptor to mediate a type-specific herpes simplex virus infection via glycoprotein B.
    Dyer AP; Banfield BW; Martindale D; Spannier DM; Tufaro F
    J Virol; 1997 Jan; 71(1):191-8. PubMed ID: 8985338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
    Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
    Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
    Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
    Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSV neutralization by the microbicidal candidate C5A.
    de Witte L; Bobardt MD; Chatterji U; van Loenen FB; Verjans GM; Geijtenbeek TB; Gallay PA
    PLoS One; 2011 May; 6(5):e18917. PubMed ID: 21573158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
    Bourinbaiar AS; Coleman CF
    Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
    Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
    Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
    J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal Gel Formulation Developed for Anti-Human Immunodeficiency Virus (HIV)-1 Activity Also Inhibits In Vitro HSV-2 Infection.
    Mishra NN; Kesharwani A; Agarwal A; Polachira SK; Nair R; Gupta SK
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30352961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.